Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its G7 acetabular system for hip ...
Zimmer Biomet earns FDA clearance for the G7 Acetabular System, enabling U.S. commercialization of this advanced hip implant.
WARSAW, Ind., Oct. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...
(RTTNews) - The U.S. Food and Drug Administration has issued a safety alert about the increased risk of thigh bone fracture after surgery with the use of the Zimmer Biomet CPT Hip System, which was ...
Zimmer Biomet Holdings, Inc (NYSE:ZBH) announced plans to phase out its CPT Hip System by December. The decision comes on the heels of a warning from the U.S. Food and Drug Administration (FDA), ...
The global hip replacement market is experiencing significant growth, driven by an aging population, rising obesity, and ...
Zimmer Biomet and Apple teamed up to produce the “mymobility” Apple Watch and iPhone app that connects patients and surgical care teams following knee and hip replacement surgery. Zimmer Biomet is ...
iTaperloc ® Complete and iG7 ™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results